HLA-A2 Antigen

"HLA-A2 Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A specific HLA-A surface antigen subtype. Members of this subtype contain alpha chains that are encoded by the HLA-A*02 allele family.

Descriptor ID	D015789
MeSH Number(s)	D12.776.395.550.489.400.020 D12.776.543.550.439.400.020 D23.050.301.500.100.400.020 D23.050.301.500.450.370.020 D23.050.705.552.100.400.020 D23.050.705.552.450.370.374
Concept/Terms	HLA-A2 Antigen HLA-A2 Antigen Antigen, HLA-A2 HLA A2 Antigen HLA-A2 HLA Class I Histocompatibility Antigen, A-2 alpha Chain HLA Class I Histocompatibility Antigen, A-2 alpha Chain HLA Class I Histocompatibility Antigen, A 2 alpha Chain

Below are MeSH descriptors whose meaning is more general than "HLA-A2 Antigen".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Glycoproteins [D12.776.395]
Membrane Glycoproteins [D12.776.395.550]
Histocompatibility Antigens Class I [D12.776.395.550.489]
HLA-A Antigens [D12.776.395.550.489.400]
HLA-A2 Antigen [D12.776.395.550.489.400.020]
Membrane Proteins [D12.776.543]
Membrane Glycoproteins [D12.776.543.550]
Histocompatibility Antigens Class I [D12.776.543.550.439]
HLA-A Antigens [D12.776.543.550.439.400]
HLA-A2 Antigen [D12.776.543.550.439.400.020]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Surface [D23.050.301]
Histocompatibility Antigens [D23.050.301.500]
Histocompatibility Antigens Class I [D23.050.301.500.100]
HLA-A Antigens [D23.050.301.500.100.400]
HLA-A2 Antigen [D23.050.301.500.100.400.020]
HLA Antigens [D23.050.301.500.450]
HLA-A Antigens [D23.050.301.500.450.370]
HLA-A2 Antigen [D23.050.301.500.450.370.020]
Isoantigens [D23.050.705]
Histocompatibility Antigens [D23.050.705.552]
Histocompatibility Antigens Class I [D23.050.705.552.100]
HLA-A Antigens [D23.050.705.552.100.400]
HLA-A2 Antigen [D23.050.705.552.100.400.020]
HLA Antigens [D23.050.705.552.450]
HLA-A Antigens [D23.050.705.552.450.370]
HLA-A2 Antigen [D23.050.705.552.450.370.374]

Below are MeSH descriptors whose meaning is related to "HLA-A2 Antigen".

Below are MeSH descriptors whose meaning is more specific than "HLA-A2 Antigen".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "HLA-A2 Antigen" by people in this website by year, and whether "HLA-A2 Antigen" was a major or minor topic of these publications.

Bar chart showing 2 publications over 2 distinct years, with a maximum of 1 publications in 2010 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	0	1	1
2013	0	1	1

Below are the most recent publications written about "HLA-A2 Antigen" by people in Profiles.

Soysal SD, Muenst S, Kan-Mitchell J, Huarte E, Zhang X, Wilkinson-Ryan I, Fleming T, Tiriveedhi V, Mohanakumar T, Li L, Herndon J, Oertli D, Goedegebuure SP, Gillanders WE. Identification and translational validation of novel mammaglobin-A CD8 T cell epitopes. Breast Cancer Res Treat. 2014 Oct; 147(3):527-37.

View in: PubMed
Xu W, Watts DM, Costanzo MC, Tang X, Venegas LA, Jiao F, Sette A, Sidney J, Sewell AK, Wooldridge L, Makino S, Morrill JC, Peters CJ, Kan-Mitchell J. The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responses. PLoS One. 2013; 8(3):e59210.

View in: PubMed
Subramanya S, Armant M, Salkowitz JR, Nyakeriga AM, Haridas V, Hasan M, Bansal A, Goepfert PA, Wynn KK, Ladell K, Price DA, N M, Kan-Mitchell J, Shankar P. Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA. Mol Ther. 2010 Nov; 18(11):2028-37.

View in: PubMed
Schaubert KL, Price DA, Salkowitz JR, Sewell AK, Sidney J, Asher TE, Blondelle SE, Adams S, Marincola FM, Joseph A, Sette A, Douek DC, Ayyavoo V, Storkus W, Leung MY, Ng HL, Yang OO, Goldstein H, Wilson DB, Kan-Mitchell J. Generation of robust CD8+ T-cell responses against subdominant epitopes in conserved regions of HIV-1 by repertoire mining with mimotopes. Eur J Immunol. 2010 Jul; 40(7):1950-62.

View in: PubMed
Schaubert KL, Price DA, Frahm N, Li J, Ng HL, Joseph A, Paul E, Majumder B, Ayyavoo V, Gostick E, Adams S, Marincola FM, Sewell AK, Altfeld M, Brenchley JM, Douek DC, Yang OO, Brander C, Goldstein H, Kan-Mitchell J. Availability of a diversely avid CD8+ T cell repertoire specific for the subdominant HLA-A2-restricted HIV-1 Gag p2419-27 epitope. J Immunol. 2007 Jun 15; 178(12):7756-66.

View in: PubMed
Mitchell MS, Lund TA, Sewell AK, Marincola FM, Paul E, Schroder K, Wilson DB, Kan-Mitchell J. The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2. Cancer Immunol Immunother. 2007 Mar; 56(3):287-301.

View in: PubMed
Kan-Mitchell J, Bisikirska B, Wong-Staal F, Schaubert KL, Bajcz M, Bereta M. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. J Immunol. 2004 May 01; 172(9):5249-61.

View in: PubMed
Mitchell MS, Kan-Mitchell J, Morrow PR, Darrah D, Jones VE, Mescher MF. Phase I trial of large multivalent immunogen derived from melanoma lysates in patients with disseminated melanoma. Clin Cancer Res. 2004 Jan 01; 10(1 Pt 1):76-83.

View in: PubMed
Mitchell MS, Kan-Mitchell J, Minev B, Edman C, Deans RJ. A novel melanoma gene (MG50) encoding the interleukin 1 receptor antagonist and six epitopes recognized by human cytolytic T lymphocytes. Cancer Res. 2000 Nov 15; 60(22):6448-56.

View in: PubMed
Schmidt H, Forsthuber T, B?hring HJ, M?ller CA. Differential expression of the HLA-B7 and the HLA-A2 gene in transfected mouse L(tk-) cells after stimulation by mouse interferon. Immunobiology. 1987 Jan; 174(1):51-66.

View in: PubMed

People

Explore

Similar Concepts

Top Journals